Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.
One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.Factors such as the dominance of market by biologics will drive this market's growth prospects for the near future. Biologics account for over 18% of the global pharmaceutical sales, outpacing the sales of branded pharmaceuticals. These drugs will continue to outperform other pharmaceuticals in terms of product sales as there is an increasing need for innovative products as effective treatment options for a range of indications.
The report details the trend, potential and market size of Systemic Psoriasis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Systemic Psoriasis Therapeuticsmarket, defines the market attractiveness level of Systemic Psoriasis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Systemic Psoriasis Therapeutics industry, describes the types of Systemic Psoriasis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Systemic Psoriasis Therapeutics market and the development prospects and opportunities of Systemic Psoriasis Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Systemic Psoriasis Therapeutics market in Chapter 13.
By Player:
AbbVie
Amgen
Celgene
Pfizer
Johnson and Johnson
By Type:
Biologics
Small Molecules
By End-User:
Mild Psoriasis
Moderate Psoriasis
Severe Psoriasis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Systemic Psoriasis Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Systemic Psoriasis Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Systemic Psoriasis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Systemic Psoriasis Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Systemic Psoriasis Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Systemic Psoriasis Therapeutics Consumption (2017-2022)
-
7.2 United States Systemic Psoriasis Therapeutics Consumption (2017-2022)
-
7.3 Europe Systemic Psoriasis Therapeutics Consumption (2017-2022)
-
7.4 China Systemic Psoriasis Therapeutics Consumption (2017-2022)
-
7.5 Japan Systemic Psoriasis Therapeutics Consumption (2017-2022)
-
7.6 India Systemic Psoriasis Therapeutics Consumption (2017-2022)
-
7.7 South Korea Systemic Psoriasis Therapeutics Consumption (2017-2022)
8 Region and Country-wise Systemic Psoriasis Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Systemic Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Systemic Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Systemic Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Systemic Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Systemic Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Systemic Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Systemic Psoriasis Therapeutics Consumption Forecast (2022-2028)
9 Global Systemic Psoriasis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Systemic Psoriasis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biologics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Small Molecules Consumption and Growth Rate (2017-2022)
-
9.2 Global Systemic Psoriasis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Mild Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Moderate Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Severe Psoriasis Consumption and Growth Rate (2017-2022)
10 Global Systemic Psoriasis Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Systemic Psoriasis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Small Molecules Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Systemic Psoriasis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Mild Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Moderate Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Severe Psoriasis Consumption Forecast and Growth Rate (2022-2028)
11 Global Systemic Psoriasis Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Systemic Psoriasis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Systemic Psoriasis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Systemic Psoriasis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Systemic Psoriasis Therapeutics Market Competitive Analysis
-
14.1 AbbVie
-
14.1.1 AbbVie Company Details
-
14.1.2 AbbVie Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AbbVie Systemic Psoriasis Therapeutics Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Systemic Psoriasis Therapeutics Product and Service
-
14.3 Celgene
-
14.3.1 Celgene Company Details
-
14.3.2 Celgene Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Systemic Psoriasis Therapeutics Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Systemic Psoriasis Therapeutics Product and Service
-
14.5 Johnson and Johnson
-
14.5.1 Johnson and Johnson Company Details
-
14.5.2 Johnson and Johnson Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson and Johnson Systemic Psoriasis Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Systemic Psoriasis Therapeutics
-
Figure Systemic Psoriasis Therapeutics Picture
-
Table Global Systemic Psoriasis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Systemic Psoriasis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Systemic Psoriasis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Systemic Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Systemic Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Systemic Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Systemic Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Systemic Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Systemic Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Systemic Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Systemic Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Systemic Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Systemic Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Systemic Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Systemic Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Systemic Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Small Molecules Consumption and Growth Rate (2017-2022)
-
Figure Global Mild Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Moderate Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Severe Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small Molecules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mild Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderate Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Severe Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Systemic Psoriasis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Systemic Psoriasis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Systemic Psoriasis Therapeutics Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Systemic Psoriasis Therapeutics Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Systemic Psoriasis Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Systemic Psoriasis Therapeutics Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Systemic Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Systemic Psoriasis Therapeutics Product and Service
-
